Sancuso (Kyowa Kirin, Inc.)
Welcome to the PulseAid listing for the Sancuso drug offered from Kyowa Kirin, Inc.. This Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Kyowa Kirin, Inc. |
NON-PROPRIETARY NAME: | granisetron |
SUBSTANCE NAME: | GRANISETRON |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |
ROUTE: | TRANSDERMAL |
DOSAGE FORM: | PATCH |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2008-09-12 |
END MARKETING DATE: | 0000-00-00 |
Sancuso HUMAN PRESCRIPTION DRUG Details:
Item Description | Sancuso from Kyowa Kirin, Inc. |
LABELER NAME: | Kyowa Kirin, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3.1(mg/24h) |
START MARKETING DATE: | 2008-09-12 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 42747-726_f743a972-af5d-4b51-9431-e1f5575fc638 |
PRODUCT NDC: | 42747-726 |
APPLICATION NUMBER: | NDA022198 |
Other GRANISETRON Pharmaceutical Manufacturers / Labelers: